Sole general partner Andrew Gluck, a marketer with exceeding a decade's track record, invests in DTC, AdTech and eCommerce enablement, acting as a embedded partner on acquisition, funnel and channels; accepts cold pitches.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Seed/early-phase AI-native business software investor making ~7 new investments yearly, originated the Diversity Rider to include underrepresented investors, and pursues fewer-bets, deeper relationships; 60% reach Series B/C. With a disciplined investment approach, the team drives value for both founders and investors.
Targets Black, Latin, and female founders as the mainstream growth market and systematically connects portfolio founders to Fortune 500 LPs through its programmatic Diversity Investing API℠. With a disciplined investment approach, the team drives value for both founders and investors.
Targets fintech–commerce intersections to advance the economic yield of financial innovation, leveraging an LP network of C-suite leaders and family offices for customers, distribution and follow-on capital. The firm maintains a forward-looking approach in the evolving financial technology space.
Seed investor making repeatable first institutional checks ($100K–$500K) into pre-vetted, capital-efficient tech-enabled startup ventures (biotech to industrial AI) via a proprietary curated deal network and Wall Street finance discipline. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Solo-GP, small vehicle writing ~$500K non-lead checks that sources and supports fintech founders via a 1,500+ founder Slack community, Rex Salisbury's podcast/newsletter, and LP operator co-investment/distribution. With a disciplined investment approach, the team drives value for both founders and investors.
Pre-seed firm (leads $500K–$2M rounds) guaranteeing funds in 10 business days via Pre-Seed Fast Track, providing serial-founder, operator, and Ph.D.-level technical expertise for biobanking, robotics, bio tooling. The firm continues to build its presence across the venture capital landscape.
